Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System-Reference-Cited by-同舟云学术

Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System

Author:

Flaig T.¹,Douros A.¹,Bronder E.¹,Klimpel A.¹,Kreutz R.¹,Garbe E.²³

Affiliation:

1. Department of Clinical Pharmacology and Toxicology; Charité-Universitätsmedizin Berlin; Berlin Germany

2. Leibniz Institute for Prevention Research and Epidemiology BIPS; Bremen Germany

3. Faculty of Human and Health Sciences; University of Bremen; Bremen Germany

Funder

Federal Institute for Drugs and Medical Devices

GlaxoSmithKline

Bayer

Mundipharma

Novartis

Teva

Takeda Pharmaceuticals U.S.A.

Sanofi

Celgene

Bayer Pharma

Berlin Chemie Menarini

Bristol-Myers Squibb

Daiichi-Sankyo

Servier

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference33 articles.

1. Drug-induced pancreatitis;Nitsche;Curr Gastroenterol Rep,2012

5. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study;Floyd;Am J Gastroenterol,2003

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献